BCM
MYOK

Bayesian Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bayesian Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,269
Closed -$311K – 788
2017
Q3 		$311K Buy
+7,269
New +$232K 0.07% 358

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bayesian Capital Management's MYOK Position: Q4 2017 in Review

Bayesian Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 7,269 shares — an estimated $311K sold.

Bayesian Capital Management first reported a position in MYOK in Q3 2017 and held it in 1 quarter. The position peaked at $311K in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • Bayesian Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 7,269 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $311K.
  • Bayesian Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Bayesian Capital Management's MyoKardia, Inc. Common Stock position peaked at $311K in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Bayesian Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.